INNOVATIVE TECHNOLOGIES FOR ENHANCING FUNCTION FOR INDIVIDUALS WITH DISABILITIES - PA-02-071 - ADDENDUM Release Date: March 21, 2002 NOTICE: NOT-DA-02-006 National Institute on Drug Abuse (NIDA) (www.nida.nih.gov) PURPOSE This addendum is to program announcement PA-02-071, which was released in the NIH Guide for Grants and Contracts on March 4, 2002 at https://grants.nih.gov/grants/guide/pa-files/PA-02-071.html. This purpose of this program announcement is to encourage basic research on the structures of membrane proteins at atomic resolution. This addendum adds the National Institute on Drug Abuse (NIDA) as a participating institute in this program announcement. The following are NIDA contacts: Direct inquiries regarding programmatic issues to: Charles Sharp, Ph.D. Division of Neuroscience and Behavioral Research National Institute on Drug Abuse 6001 Executive Boulevard, Room 4282, MSC 9581 Bethesda, MD 20892-9555 Telephone: (301)-443-1887 Fax: 301-594-6043 E-mail: csharp@nida.nih.gov Direct inquiries regarding fiscal matters to: Gary Fleming, J.D., M.A. Grants Management Branch National Institute on Drug Abuse 6001 Executive Boulevard, Room 3158, MSC 9541 Bethesda, MD 20892-9541 Telephone: (301)-443-6710 E-mail: gf6s@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |